SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-078582
Filing Date
2023-03-24
Accepted
2023-03-24 08:00:58
Documents
7
Period of Report
2023-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d404272ddef14a.htm DEF 14A 1289875
2 GRAPHIC g404272dsp001.jpg GRAPHIC 220512
3 GRAPHIC g404272dsp002.jpg GRAPHIC 601755
4 GRAPHIC g404272g06m01.jpg GRAPHIC 45060
5 GRAPHIC g404272g06m02.jpg GRAPHIC 39433
6 GRAPHIC g404272g24g28.jpg GRAPHIC 192268
7 GRAPHIC g404272g38f03.jpg GRAPHIC 332094
  Complete submission text file 0001193125-23-078582.txt   3261724
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36697 | Film No.: 23757695
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences